Khaled Ali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Khaled Ali has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Mhd Baraa Habib
Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar
4 shared publications Mhd Baraa Habib
Internal Medicine Department Hamad Medical Corporation Doha Qatar
3 shared publicationsIheb Bougmiza
Community Medicine Department, Primary Health Care Corporation, Doha, Qatar
2 shared publications- Mohammad Altermanini
Hamad Medical Corporation
2 shared publications Abdulaziz Zafar
Internal Medicine, Hamad Medical Corporation, Doha, Qatar
1 shared publicationAbdullah Hamad
Nephrology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
1 shared publication
Latest Publications
- Open Access
- 11 August 2024
- Published by Wiley in Respirology Case Reports
- Vol. 12 (8) , e01441
Diffuse large B‐cell lymphoma presenting with pulmonary artery compression symptoms, case reports
Mediastinal diffuse large B‐cell lymphoma (DLBC) may manifest in different presentations including systemic symptoms and local mass symptoms. We report two cases of diffuse large B‐cell lymphoma presenting with pulmonary artery compression symptoms. The first case is of a 38‐year‐old Asian man which mimicked pulmonary embolism, and the second one is of a 27‐year‐old Asian woman who presented with fainting and respiratory symptoms due to local mass effect. Both cases were significantly improved after treatment. Local mass effect symptoms may be the first clinical presentation in DLBC lymphoma and should not be overlooked.
- 11 August 2024
- Published by Wiley in Respirology Case Reports
- Vol. 12 (8) , e01441
Open AccessDiffuse large B‐cell lymphoma presenting with pulmonary artery compression symptoms, case reports
Mediastinal diffuse large B‐cell lymphoma (DLBC) may manifest in different presentations including systemic symptoms and local mass symptoms. We report two cases of diffuse large B‐cell lymphoma presenting with pulmonary artery compression symptoms. The first case is of a 38‐year‐old Asian man which mimicked pulmonary embolism, and the second one is of a 27‐year‐old Asian woman who presented with fainting and respiratory symptoms due to local mass effect. Both cases were significantly improved after treatment. Local mass effect symptoms may be the first clinical presentation in DLBC lymphoma and should not be overlooked.
- Open Access
- 25 August 2023
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 16 (1) , 728-733
Pembrolizumab-Induced Rhabdomyolysis in a Clear Cell Renal Cell Carcinoma Patient: A Case Report
Pembrolizumab is one of the approved treatments for many types of cancer including clear cell renal cell carcinoma (ccRCC). It has improved the prognosis of renal cell carcinoma, yet has many possible immune-related side effects. We discuss a rare case of rhabdomyolysis in an ccRCC patient treated with pembrolizumab. The case was complicated with acute kidney injury and severe hypothyroidism, which can be attributed to pembrolizumab.
- 25 August 2023
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 16 (1) , 728-733
Open AccessPembrolizumab-Induced Rhabdomyolysis in a Clear Cell Renal Cell Carcinoma Patient: A Case Report
Pembrolizumab is one of the approved treatments for many types of cancer including clear cell renal cell carcinoma (ccRCC). It has improved the prognosis of renal cell carcinoma, yet has many possible immune-related side effects. We discuss a rare case of rhabdomyolysis in an ccRCC patient treated with pembrolizumab. The case was complicated with acute kidney injury and severe hypothyroidism, which can be attributed to pembrolizumab.
- Open Access
- 1 January 2023
- Published by Hamad bin Khalifa University Press (HBKU Press) in Qatar Medical Journal
- Vol. 2023 (4) , 33
Determinants of vaccine adherence among non-dialysis chronic kidney disease patients in Qatar
Introduction: Chronic kidney disease (CKD) is a global health problem. Reduced innate and adaptive immunological responses predispose CKD patients to infections. Despite the clinical and epidemiological importance of CKD and the great value of vaccination as a prophylactic measure, the utilization of recommended vaccines in Qatar has not yet been evaluated. Methods: We conducted a cross-sectional study to estimate the level of influenza, pneumococcal, and hepatitis B vaccination and the predictors of adherence to these recommended vaccines among non-dialysis CKD patients receiving renal ambulatory care in Qatar from 1 September 2020 to 30 April 2021. Complete vaccination was defined as receiving the three vaccines, and partial vaccination was defined as receiving one or two vaccines. The full and partial vaccination predictors were assessed using multivariate logistic regression and reported as odds ratio (OR) with p<0.05 indicating statistical significance. Results: 416 non-dialysis CKD patients were included in our analysis. 73% were males; the mean age was 56 ± 15 years. More than 50% of the patients were from the Middle East, followed by 36% from Asia. Most patients had concurrent hypertension, concurrent diabetes mellitus, and were stage V CKD. Only 12% of the patients were fully vaccinated, while 73% received partial vaccination. The predictors of vaccination included age, gender, Asian origin, employment, living conditions, concurrent medical conditions, CKD stage, allergy to medications, and use of injectable medications. Only stage V CKD positively predicted adherence to full and partial vaccinations in non-dialysis CKD patients. Conclusion: There is very low adherence to the recommended vaccines in CKD patients, with a prevalence of complete vaccination of 12% only. Increased public awareness about the importance of vaccination in CKD may improve the adherence rates among these patients in Qatar.
- 1 January 2023
- Published by Hamad bin Khalifa University Press (HBKU Press) in Qatar Medical Journal
- Vol. 2023 (4) , 33
Open AccessDeterminants of vaccine adherence among non-dialysis chronic kidney disease patients in Qatar
Introduction: Chronic kidney disease (CKD) is a global health problem. Reduced innate and adaptive immunological responses predispose CKD patients to infections. Despite the clinical and epidemiological importance of CKD and the great value of vaccination as a prophylactic measure, the utilization of recommended vaccines in Qatar has not yet been evaluated. Methods: We conducted a cross-sectional study to estimate the level of influenza, pneumococcal, and hepatitis B vaccination and the predictors of adherence to these recommended vaccines among non-dialysis CKD patients receiving renal ambulatory care in Qatar from 1 September 2020 to 30 April 2021. Complete vaccination was defined as receiving the three vaccines, and partial vaccination was defined as receiving one or two vaccines. The full and partial vaccination predictors were assessed using multivariate logistic regression and reported as odds ratio (OR) with p<0.05 indicating statistical significance. Results: 416 non-dialysis CKD patients were included in our analysis. 73% were males; the mean age was 56 ± 15 years. More than 50% of the patients were from the Middle East, followed by 36% from Asia. Most patients had concurrent hypertension, concurrent diabetes mellitus, and were stage V CKD. Only 12% of the patients were fully vaccinated, while 73% received partial vaccination. The predictors of vaccination included age, gender, Asian origin, employment, living conditions, concurrent medical conditions, CKD stage, allergy to medications, and use of injectable medications. Only stage V CKD positively predicted adherence to full and partial vaccinations in non-dialysis CKD patients. Conclusion: There is very low adherence to the recommended vaccines in CKD patients, with a prevalence of complete vaccination of 12% only. Increased public awareness about the importance of vaccination in CKD may improve the adherence rates among these patients in Qatar.
- 30 August 2022
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 37 (1) , 24-35
COVID-19 perceived stigma among survivors: A cross-sectional study of prevalence and predictors
- 30 August 2022
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 37 (1) , 24-35
COVID-19 perceived stigma among survivors: A cross-sectional study of prevalence and predictors
- Open Access
- 10 June 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (23) , e29236
Mantle cell lymphoma presenting with severe upper gastrointestinal bleeding
Introduction: Although it usually involves extranodal sites such as the gastrointestinal tract in more than 80% of cases, mantle cell lymphoma is considered a rare cause of gastrointestinal bleeding, especially severe and life-threatening bleeding. Patient concern: A 60-year-old man with peptic ulcer disease, who presented with severe upper gastrointestinal (GI) bleeding and large gastric ulcer. Diagnosis: Primary gastric mantle cell lymphoma. Interventions: He was treated conservatively with blood transfusion and started on Traneximic acid for 3 days. Then, the patient underwent urgent hemostatic radiotherapy. Outcomes: The patient became stable and kept in the hospital for monitoring with a definite diagnosis of stage IV Mantle cell lymphoma is made. Conclusion: Mantle cell lymphoma should be kept in mind when assessing massive upper GI bleeding, as an unusual cause of bleeding gastric ulcer, given that bleeding is an uncommon presenting feature of GI lymphoma.
- 10 June 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (23) , e29236
Open AccessMantle cell lymphoma presenting with severe upper gastrointestinal bleeding
Introduction: Although it usually involves extranodal sites such as the gastrointestinal tract in more than 80% of cases, mantle cell lymphoma is considered a rare cause of gastrointestinal bleeding, especially severe and life-threatening bleeding. Patient concern: A 60-year-old man with peptic ulcer disease, who presented with severe upper gastrointestinal (GI) bleeding and large gastric ulcer. Diagnosis: Primary gastric mantle cell lymphoma. Interventions: He was treated conservatively with blood transfusion and started on Traneximic acid for 3 days. Then, the patient underwent urgent hemostatic radiotherapy. Outcomes: The patient became stable and kept in the hospital for monitoring with a definite diagnosis of stage IV Mantle cell lymphoma is made. Conclusion: Mantle cell lymphoma should be kept in mind when assessing massive upper GI bleeding, as an unusual cause of bleeding gastric ulcer, given that bleeding is an uncommon presenting feature of GI lymphoma.
- Open Access
- 19 November 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (11) , e05128
Bronchopleural fistula causing persistent pneumothorax in COVID‐19 pneumonia patient with no risk factors
Although pneumothorax is a well‐known complication of COVID‐19 pneumonia especially in patients requiring mechanical ventilation, bronchopleural fistula causing persistent pneumothorax in sole COVID‐19 pneumonia is extremely rare. In this case, we illustrate that bronchopleural fistula can be found in COVID‐19 pneumonia, even with no risk factors nor mechanical ventilation administration.
- 19 November 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (11) , e05128
Open AccessBronchopleural fistula causing persistent pneumothorax in COVID‐19 pneumonia patient with no risk factors
Although pneumothorax is a well‐known complication of COVID‐19 pneumonia especially in patients requiring mechanical ventilation, bronchopleural fistula causing persistent pneumothorax in sole COVID‐19 pneumonia is extremely rare. In this case, we illustrate that bronchopleural fistula can be found in COVID‐19 pneumonia, even with no risk factors nor mechanical ventilation administration.
- Open Access
- 6 November 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (11) , e04851
Eslicarbazepine‐induced severe hyponatremia resulted in generalized tonic‐clonic seizure
Although eslicarbazepine is an anti‐seizure medication, it may result in seizure worsening if its use is complicated by severe hyponatremia, even long time after commencing this medication. The treatment is a replacement for another ASM.
- 6 November 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (11) , e04851
Open AccessEslicarbazepine‐induced severe hyponatremia resulted in generalized tonic‐clonic seizure
Although eslicarbazepine is an anti‐seizure medication, it may result in seizure worsening if its use is complicated by severe hyponatremia, even long time after commencing this medication. The treatment is a replacement for another ASM.
- Open Access
- 18 June 2021
- Published by Springer Nature in Research Square
Mantle Cell Lymphoma Presenting with Severe Upper GI Bleeding.
Although it usually involves extra-nodal sites such as gastrointestinal tract in more than 80% of case, Mantle cell lymphoma is considered a rare cause of gastrointestinal bleeding, especially a severe and life-threatening bleeding. We are reporting a 60 year old man, known to have peptic ulcer disease, who presented with a severe upper GI bleeding and found to have large gastric ulcer, which diagnosed as primary gastric mantle cell lymphoma.
- 18 June 2021
- Published by Springer Nature in Research Square
Open AccessMantle Cell Lymphoma Presenting with Severe Upper GI Bleeding.
Although it usually involves extra-nodal sites such as gastrointestinal tract in more than 80% of case, Mantle cell lymphoma is considered a rare cause of gastrointestinal bleeding, especially a severe and life-threatening bleeding. We are reporting a 60 year old man, known to have peptic ulcer disease, who presented with a severe upper GI bleeding and found to have large gastric ulcer, which diagnosed as primary gastric mantle cell lymphoma.